Information regarding trading and terms for Diamyd Medical AB TO will be announced next week. For further information, please call Issuer Surveillance at +46 8 405 7050
First North:Disregard Marketplace Announcement 117/08: New equity right for trading, Diamyd Medical AB TO. (122/08)
| Source: Nasdaq Stockholm AB